Shin Nippon Biomedical Laboratories, Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
11.55 | 110.39 | -89.53% | 11.36 | +1.66% |
| P/S |
|
2.42 | 74.99 | -96.78% |
|
|
| P/BV |
|
1.87 | 70.27 | -97.34% |
|
|
| P/FCF |
|
-13.75 | 79.2 | -117.36% |
|
|
| Ev/Ebitda |
|
8.89 | 16.85 | -47.27% |
|
|
| Ev/S |
|
3.02 | 80.73 | -96.26% |
|
|
| Ev/FCF |
|
-12.28 | 24.73 | -149.67% |
|
|
| E/P |
|
0.0619 | -0.1555 | -139.81% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
33.95 | -144.44 | -123.51% | 38.48 | -11.75% |
| ROE |
|
18.34 | -9.24 | -298.41% |
|
|
| ROA |
|
8.28 | -9.69 | -185.49% |
|
|
| ROIC |
|
18.08 | 9.09 | 98.88% |
|
|
| ROS |
|
20.91 | -211.07 | -109.91% |
|
|
| ROCE |
|
20.82 | 6.03 | 245.22% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
5/10
|
2.92 | -1.04 | -379.75% | 2.26 | +29.01% |
| Nеt Debt/Ebitda |
|
1.77 | 12.51 | -85.83% |
|
|
| Debt/Ratio |
|
0.3432 | 0.1401 | 144.95% |
|
|
| Debt/Equity |
|
1.39 | 40.14 | -96.54% |
|
|
| Debt/Net Income |
|
4.73 | -1.96 | -341.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
5.52 | 2.65 | 107.99% | 2.54 | +117.49% |
| Number of years of dividend growth |
|
0 | 1.28 | -100% | ||
| DSI |
|
1 | 0.7376 | 35.58% |
|
|
| Average dividend growth |
|
28.33 | -18.51 | -253.11% |
|
|
| Average percentage for 5 years |
|
2.54 | 1.9 | 33.42% |
|
|
| Average percentage for payments |
|
17.81 | 32.83 | -45.76% |
|
|
| Difference from average difference in sector |
|
2.87 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
9/10
|
81.67 | 87.09 | -6.22% | ||
| Growth impulse Ebitda in 5 years |
|
111.82 | 69.14 | 61.73% | ||
| Growth impulse Net Income in 5 years |
|
116.91 | 31.67 | 269.15% | ||
| Growth impulse FCF in 5 years |
|
-463.05 | -20.71 | 2135.88% | ||
| Growth impulse EPS in 5 years |
|
116.89 | -36.16 | -423.26% |
IP Score
7.14/10
